Related Experiment Video

Updated: Jul 9, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Screening for rejection in symptomatic pediatric heart transplant recipients: the sensitivity of BNP

Miwa Geiger1, Danielle Harake, Nancy Halnon

  • 1Mattel Children's Hospital, University of California at Los Angeles, Los Angeles, CA 90027, USA. miwageiger@msn.com

Pediatric Transplantation
|December 19, 2007
PubMed

Insights

Brain natriuretic peptide (BNP) is a sensitive biomarker for detecting acute rejection in pediatric heart transplant patients. This screening tool helps clinicians identify graft dysfunction in children presenting with non-specific symptoms.

Area of Science:

  • Pediatric Cardiology
  • Transplant Medicine
  • Biomarker Discovery

Background:

  • The pediatric heart transplant population is growing, increasing the need for effective screening methods for acute rejection.
  • Symptoms of graft dysfunction in children are often nonspecific and can mimic other common childhood illnesses.
  • Accurate and timely diagnosis of acute rejection is crucial for graft survival in pediatric heart transplant recipients.

Purpose of the Study:

  • To evaluate the diagnostic utility of B-type natriuretic peptide (BNP) as a biomarker for acute rejection in symptomatic pediatric heart transplant (OHT) patients.
  • To assess the sensitivity and specificity of BNP in identifying acute allograft rejection in children.
  • To determine if BNP can aid clinical decision-making in acute care settings for pediatric heart transplant recipients.

Main Methods:

  • Retrospective review of 122 urgent care and emergency room visits from 53 symptomatic pediatric OHT patients.
  • Analysis of the relationship between BNP levels, presenting symptoms, and clinical diagnosis at each visit.
  • Generation of a Receiver Operating Characteristic (ROC) curve to determine BNP's accuracy as a screening tool for acute rejection.

Main Results:

  • A BNP level greater than 700 pg/mL demonstrated 100% sensitivity for detecting acute allograft rejection in the studied pediatric heart transplant population.
  • The specificity of BNP for detecting acute rejection was 92%, with a 100% negative predictive value (NPV).
  • BNP levels effectively correlated with the clinical diagnosis of acute rejection in symptomatic children post-heart transplant.

Conclusions:

  • BNP serves as a highly sensitive and specific screening biomarker for acute rejection in symptomatic pediatric heart transplant patients.
  • BNP testing can assist healthcare providers in the early identification of allograft rejection, facilitating timely intervention.
  • The findings support the use of BNP as a valuable tool to improve the management of pediatric heart transplant recipients experiencing symptoms suggestive of rejection.

More Related Videos

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography08:21

Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography

Published on: October 11, 2022

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...